U.S. FDA approves pair of gene therapies for sickle cell disease Subject: Science and Tech Section: Biotechnology Context:  The U.S. Food and Drug Administration (FDA) approved a pair of gene therapies for sickle cell disease, including the first treatment based on the breakthrough CRISPR gene editing technology. Key details: The agency approved Lyfgenia […]